Scarica l'app Stockscreener
9.85
0.10%
-0.010
Dopo l'orario di chiusura:
9.85
Precedente Chiudi:
$9.86
Aprire:
$9.85
Volume 24 ore:
1,800
Relative Volume:
0.03
Capitalizzazione di mercato:
$332.52M
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
-0.10%
1M Prestazione:
+0.00%
6M Prestazione:
+0.00%
1 anno Prestazione:
+0.00%
Intervallo 1D:
$9.85
$9.86
Intervallo di 1 settimana:
$9.85
$9.87
Portata 52W:
$9.84
$9.87
Bleichroeder Acquisition Corp I Stock (BACQ) Company Profile
Nome
Bleichroeder Acquisition Corp I
Settore
Industria
Telefono
(917) 769-2999
Indirizzo
1345 AVENUE OF THE AMERICAS, NEW YORK
Confronta BACQ con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
BACQ
Bleichroeder Acquisition Corp I
|
9.85 | 332.52M | 0 | 0 | 0 | 0.00 |
|
LION
Lionsgate Studios Corp
|
7.06 | 2.04B | 3.13B | 50.80M | 555.00M | 0.1772 |
|
OBDE
Blue Owl Capital Corp Iii
|
15.04 | 1.86B | 244.17M | 216.39M | -461.29M | 1.7559 |
|
AACT
Ares Acquisition Corporation Ii
|
10.95 | 684.38M | 0 | 16.92M | -1.35M | 0.29 |
|
ANSC
Agriculture Natural Solutions Acquisition Corp
|
10.47 | 451.52M | 0 | 1.30M | 0 | 0.0301 |
|
AAM
Aa Mission Acquisition Corp
|
10.08 | 443.34M | 0 | 0 | 0 | 0.00 |
Bleichroeder Acquisition Corp I Borsa (BACQ) Ultime notizie
Bleichroeder Acquisition Corp. I (BACQ) reports earnings - Quartz
Bleichroeder Acquisition Corp. I Announces the Separate Trading of its Class A Ordinary Shares and Rights, Commencing December 2, 2024 - The Manila Times
Revival Gold Announces AGM Results and Transition in Exploration Leadership - The Manila Times
Bleichroeder Acquisition Corp. I Announces Unit Split for Nasdaq Trading - StockTitan
Bleichroeder Acquisition announces IPO proceeds and trust account - Investing.com
BACQUBleichroeder Acquisition Corp. I Unit Latest Stock News & Market Updates - StockTitan
U.S. IPO Weekly Recap: 2 Nano-Caps List As More Small Names Join The Pipeline - Seeking Alpha
Lexicon Announces Outcome of FDA Advisory Committee for Zynquista™ (sotagliflozin) as an Adjunct to Insulin Therapy for Glycemic Control in Adults with Type 1 Diabetes and Chronic Kidney Disease - The Manila Times
Welltower Announces Addition of Andrew Gundlach to Board of Directors - PR Newswire
Deal Watch: Private Equity-Backed Deals Headline Week - Law.com
IPO NewsUS IPO Weekly Recap: 2 SPACs debut in quiet post-holiday week - Renaissance Capital
How a hedge fund manager launched a biz journalism media start-up - Talking Biz News
Private equity manager Blackstone breaks into mutual fund business with First Eagle buy - InvestmentNews
Bleichroeder Acquisition Corp I Azioni (BACQ) Dati Finanziari
Non sono disponibili dati finanziari per Bleichroeder Acquisition Corp I (BACQ). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
0.00%
0.10%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):